INS and fatty liver disease: Located in intron. Increased liver steatosis and fibrosis, LDL, triglycerides, 2 hour plasma glucose, and risk of MASLD; decreased fasting glucose, insulin, and HOMA-IR. In strong linkage disequilibrium with rs1260326 and rs3817588